Agreed at this point, they are gathering information for very little outlay on any other drugs that can be used in combo and how that works for them, they have done the dosing trials for Cantrixil now, phase 2 will come, a lot of work was done by Yale looking at it, they proved that it is was a pan acting drug for all sorts of cancers, the patent is oldish now, they will need to reset the patent clock with a new patent, I think it may be via a combo using their own in house drugs?
